Skip to content
DataLookout
Menu

NCT03727399

Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

StatusEnrolling by Invitation
PhaseNot specified
SponsorMabylon AG
Primary completion (estimated)

At risk: Primary completion moved 5 years later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2025 to Dec 31, 2030
    • Eligibility criteria expanded, about 7 words
  2. Minor Site details revisedv6
  3. Notable Primary and study completion dates: Sep 30, 2024 to Dec 31, 2025v5
  4. Notable Primary and study completion dates: Sep 30, 2021 to Sep 30, 2024v4
  5. Minor Collaborators shortened, about 5 wordsv2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Antibody profiling
Timeframe: October 2018 - September 2021

Arms and interventions

Other: blood withdrawal

Sites

1 site in 1 country

  • Immunologie Zentrum ZürichZurich, Canton of Zurich, Switzerland